NCT02004041View on ClinicalTrials.gov

Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

December 10, 2013

Primary Completion Date

February 19, 2015

Study Completion Date

February 19, 2015

Conditions
Treatment-resistant Pruritus Associated With Atopic Dermatitis
Interventions
DRUG

VLY-686

DRUG

Placebo

Trial Locations (5)

22083

Vanda Investigational Site, Hamburg

24105

Vanda Investigational Site, Kiel

40225

Vanda Investigational Site, Düsseldorf

48147

Vanda Investigational Site, Münster

07740

Vanda Investigational Site, Jena

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY